Sedana Medical is listed on Nasdaq Stockholm (SEDANA).

Source: Modular Finance

Warrant and incentive programs

Sedana Medical has two outstanding warrant programs; warrant program 2022/2025:1 and 2022/2025:2. The warrants are exercisable 30 May to 30 September 2025 at a subscription price of SEK 46.24 per share, and can lead to total maximum dilution of 895,000 shares.

Sedana Medical also has a performance-based incentive program under which participants have been allotted performance-based share rights. A performance right entitles a participant, for each held right, to acquire up to one share in the company for a price of SEK 26.33, provided that the company achieves a performance target with respect to average annual growth rate concerning net revenue for the financial years 2024, 2025 and 2026. A total number of 1,490,053 warrants have been issued to enable allotment under the performance rights (1,133,810 warrants) and to hedge costs of the program (356,243 warrants).

In total, Sedana Medical’s warrant programs and long-term incentive program can lead to maximum dilution of 2,385,053 shares, which corresponds to 2.40 percent of the currently outstanding shares in the company.

Analysts covering Sedana Medical
Pareto Securities, Filip Wiberg
Redeye, Oscar Bergman
SEB, Mattias Vadsten